MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
Volume 4.70M
Average 0.95M
MMED Net Income
Bottom-line profit, the starting point for calculating cash from operations.
MiniMed Group, Inc. Common StockNASDAQ: MMED
Net Income · Q1 FY2026 · quarter ended Jul 2026
Net income of $0 in Q1 FY2026
Q1 FY2026 net income was $0. Trailing-twelve-month net income was -$301M. Over 3 fiscal years it compounded at +51.0% a year.
Context
- Net income amounted to 10.2% of revenue in FY2025, up 2.9 pp from a year earlier.
- Net income grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 11 analysts of $173.85M (+154.8%) for the fiscal year ending Apr 2027, a step up from the +60.1% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJul 2026
- $0+100.0% QoQ
- Last fiscal yearApr 2026
- -$317M+60.1% YoY
- LTMJul 2026
- -$301M— YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | — | +778.4% | — |
| 1 year | +60.1% | +154.8% | +94.7 pp |
| 3-year CAGR | +51.0% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (317M) USD
- Year-over-year change
- -60.1%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2026-04-24 | (317M) | -60.1% |
| FY2024 | 2025-04-30 | (198M) | -85.0% |
| FY2023 | 2024-04-30 | (107M) | -16.3% |
| FY2022 | 2023-04-30 | (92M) | — |
Net Income vs competitors
How MMED compares with its peers on the latest reported figures
- MMED's LTM Jul 2026 net income of $301M is the 4th largest of the 7 companies compared; the peer median is $154.43M.
- Net income amounts to 9.3% of revenue for MMED, versus a peer median of 17.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $5.27B | +12.7% | +8.5% | 14.0% | |
| LTM Jun 2026 | $999.7M | +74.9% | +34.8% | 20.1% | |
| LTM Jun 2026 | $375.3M | +59.0% | +277.3% | 12.3% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $301M | — | +51.0% | 9.3% |
| LTM Mar 2026 | $94.55M | -48.6% | +29.3% | 9.2% | |
| LTM Mar 2026 | $87.19M | +17.8% | — | 214.2% | |
| LTM Mar 2026 | $66.44M | -6.4% | +4.2% | 60.3% | |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding MMED) | $154.43M | +15.3% | +29.3% | 17.1% | |
Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 | FY2025 Apr 2026 |
|---|---|---|---|---|
| Net Income | (92M) | (107M) | (198M) | (317M) |
| Depreciation & Amortization | 115M | 129M | 143M | 156M |
| Deferred Income Tax | (11M) | 3M | (2M) | (54M) |
| Stock-Based Compensation | 35M | 38M | 41M | 46M |
| Change in Working Capital | (90M) | (74M) | 122M | (166M) |
| Accounts Receivables | (70M) | (105M) | (66M) | (538M) |
| Inventory | (28M) | 5M | (19M) | (29M) |
| Accounts Payables | 14M | (4M) | 191M | 41M |
| Other Working Capital | (6M) | 30M | 16M | 360M |
| Other Non-Cash Items | 37M | 52M | 34M | 138M |
| Operating Cash Flow | (6M) | 41M | 140M | (197M) |
| Capital Expenditures | (167M) | (148M) | (193M) | (223M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (13M) | (5M) | 0 | 0 |
| Sales of Investments | 0 | 11M | 0 | 0 |
| Other Investing Activities | 0 | (15M) | 0 | (10M) |
| Investing Cash Flow | (180M) | (157M) | (193M) | (233M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 538M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 185M | 112M | 10M | 178M |
| Financing Cash Flow | 185M | 112M | 10M | 716M |
| Effect of Forex Changes | 0 | 0 | 0 | 1M |
| Net Change in Cash | (2M) | (4M) | (43M) | 287M |
| Free Cash Flow | (173M) | (107M) | (53M) | (420M) |
MiniMed Group, Inc. Common Stock
NASDAQ:MMED
Intrinsic Alpha fair value
Locked
Current Price
$16.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.